"Kaplan-Meier Estimate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
| Descriptor ID |
D053208
|
| MeSH Number(s) |
E05.318.740.998.650 N05.715.360.750.795.650 N06.850.520.830.998.650
|
| Concept/Terms |
Kaplan-Meier Estimate- Kaplan-Meier Estimate
- Estimate, Kaplan-Meier
- Kaplan-Meier Test
- Kaplan Meier Test
- Test, Kaplan-Meier
- Product-Limit Method
- Method, Product-Limit
- Methods, Product-Limit
- Product Limit Method
- Product-Limit Methods
- Kaplan-Meier Analysis
- Analysis, Kaplan-Meier
- Kaplan Meier Analysis
Kaplan-Meier Survival Curves- Kaplan-Meier Survival Curves
- Curves, Kaplan-Meier Survival
- Kaplan Meier Survival Curves
- Survival Curves, Kaplan-Meier
|
Below are MeSH descriptors whose meaning is more general than "Kaplan-Meier Estimate".
Below are MeSH descriptors whose meaning is more specific than "Kaplan-Meier Estimate".
This graph shows the total number of publications written about "Kaplan-Meier Estimate" by people in this website by year, and whether "Kaplan-Meier Estimate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 3 | 3 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kaplan-Meier Estimate" by people in Profiles.
-
Overall survival associated with CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer in the United States: A SEER-Medicare population-based study. Cancer. 2023 04 01; 129(7):1051-1063.
-
Risk of Cardiovascular Outcomes and Antihypertensive Triple Combination Therapy Among Elderly Patients with Hypertension Enrolled in a Medicare Advantage Plan (MAP). Am J Cardiovasc Drugs. 2020 Dec; 20(6):591-602.
-
Sustained delivery of a camptothecin prodrug - CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity. Int J Nanomedicine. 2019; 14:3799-3817.
-
Radiographic and clinical comparison of pegged and keeled glenoid components using modern cementing techniques: midterm results of a prospective randomized study. J Shoulder Elbow Surg. 2017 Dec; 26(12):2078-2085.
-
Assessment of Heart Transplant Waitlist Time and Pre- and Post-transplant Failure: A Mixed Methods Approach. Epidemiology. 2016 Jul; 27(4):469-76.
-
SUMOylation of HP1a supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy. Oncotarget. 2016 May 24; 7(21):30336-49.
-
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer. Oncotarget. 2016 May 03; 7(18):25930-48.
-
Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease. Parkinsonism Relat Disord. 2014 Jul; 20(7):731-7.
-
Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents. Med Care. 2012 Nov; 50(11):961-9.
-
Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob Agents Chemother. 2012 Sep; 56(9):4625-9.